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Mastitis is one of the most prevalent and costly diseases in the dairy industry with losses
attributable to reduced milk production, discarded milk, early culling, veterinary services,
and labor costs. Typically, mastitis is an inflammation of the mammary gland most often,
but not limited to, bacterial infection, and is characterized by the movement of leukocytes
and serum proteins from the blood to the site of infection. It contributes to compromised
milk quality and the potential spread of antimicrobial resistance if antibiotic treatment is not
astutely applied. Despite the implementation of management practises and genetic selec-
tion approaches, bovine mastitis control continues to be inadequate. However, some novel
genetic strategies have recently been demonstrated to reduce mastitis incidence by taking
advantage of a cow’s natural ability to make appropriate immune responses against invading
pathogens. Specifically, dairy cattle with enhanced and balanced immune responses have
a lower occurrence of disease, including mastitis, and they can be identified and selected
for using the high immune response (HIR) technology. Enhanced immune responsiveness
is also associated with improved response to vaccination, increased milk, and colostrum
quality. Since immunity is an important fitness trait, beneficial associations with longevity
and reproduction are also often noted. This review highlights the genetic regulation of the
bovine immune system and its vital contributions to disease resistance. Genetic selec-
tion approaches currently used in the dairy industry to reduce the incidence of disease
are reviewed, including the HIR technology, genomics to improve disease resistance or
immune response, as well as the Immunity+™ sire line. Improving the overall immune
responsiveness of cattle is expected to provide superior disease resistance, increasing
animal welfare and food quality while maintaining favorable production levels to feed a
growing population.
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INTRODUCTION
Mastitis, generally defined as the inflammation of the mammary
gland, is a costly and complex disease associated with variable
origin, severity, and outcome depending on the environment,
pathogen, and host (1, 2). Mastitis is caused when pathogenic
bacteria enter the sterile environment of the mammary gland,
often as a result of disruption of physical barriers such as the
teat, requiring prompt and appropriate host defenses to prevent
colonization and subsequent disease pathology (3, 4). Mastitis-
causing pathogens are commonly categorized as environmental or
contagious, although this distinction has recently been disputed
(5). Nonetheless, in general environmental pathogens have been
grouped to include coliforms like Klebsiella or Escherichia coli (E.
coli) and streptococci and are a major cause of clinical mastitis.
On the other hand, those categorized as contagious pathogens can
readily be spread from the infected quarters to other quarters of
the same cow, or other cows and include Staphylococcus aureus
(S. aureus) and Streptococcus agalactiae (6–8). Cow factors includ-
ing age, stage of lactation, and somatic cell score (SCC) history
are known to influence the occurrence of mastitis infection (9,
10). The diverse pathogens that can cause mastitis induce differ-
ent immune responses in the mammary gland, and therefore, the
host requires highly specific pathogen-dependent responses for
protection (11, 12).
Mastitis infections are described as either subclinical or clini-
cal. Subclinical mastitis is the presence of infection without local
inflammation resulting in an absence of visual signs (1). It may
involve transient cases of inflammation and abnormal milk, and if
this persists for longer than 2 months is termed chronic. Clin-
ical mastitis, on the other hand, is an inflammatory response
causing visibly abnormal milk. In the case of mild or moderate
clinical mastitis, changes in the udder may include swelling, heat,
pain, and redness. It is termed severe if the response includes sys-
temic involvement such as fever, anorexia, and shock (13, 14).
The diversity as well as the variation in prevalence and abun-
dance of mastitis-causing organisms as well as the variation in
host responses make mastitis a complex disease that continues to
be a burden for the dairy industry.
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The bovine mammary gland is equipped with a non-immune
anatomical barrier, and a plethora of immune-mediated defense
mechanisms that include innate and adaptive immune responses.
Innate immunity is relatively non-specific with rapid kinetics
while the adaptive immunity offers a highly specific response with
relatively delayed kinetics (15). Innate host-defenses depend on
germline-encoded receptors that recognize conserved structures
expressed by a wide range of microbes, and early induced cellu-
lar and soluble defenses. These natural defenses respond quickly
to microbes during early stages of infection and are tightly inte-
grated with the adaptive immune system. The innate host defenses
of the mammary gland have been reviewed extensively elsewhere
(16–18). The adaptive immune system uses a diverse repertoire
of antigen specific receptors expressed by clonally expanded B
and T-lymphocytes to regulate or eliminate the signal elicited by
recognition events. Additionally, the induced adaptive immune
response has the capacity to establish antigen specific memory for
a rapid and augmented response upon subsequent exposure to the
same antigen (19). For example, these various components of the
immune system work in collaboration both locally and systemi-
cally in an attempt to control specific mastitis pathogens invading
the mammary gland, but the details of the response is contingent
upon the stage of infection and nature of the pathogen, as well as
its interaction with the genetics of the host.
The interaction between mastitis pathogens and the host
immune system is intricate, since both have the ability to co-evolve
to recognize, respond, and adapt to the other. As such, microbial
pathogens have developed various strategies to alter and evade host
defenses in order to survive. Importantly, the host immune sys-
tem is also adaptive and has a large arsenal to control or eliminate
microbial threat. Even so, it is widely accepted that susceptibility
of individuals within a given species differs to the same microbial
pathogen. This variability in host–pathogen interaction is con-
trolled by the inherent genetic make-up of the host, including
innate and adaptive immune responses, particularly the acquired
immunological memory, as well as the nature of the microbial
pathogen (20).
Mastitis causing-bacterial pathogens are often well adapted to
the bovine host resulting in clinical signs and, occasionally, sub-
clinical infection before they lead to chronicity and persistence
in the mammary gland. Persistent intramammary infections are
frequently associated with recurrent clinical episodes and long-
term increases in milk somatic cells counts. Persistent strains
often express sets of genes that relate to their adaptation to the
intramammary milieu and allow for intracellular survival and
subsequent modulation of host-defense mechanisms (6, 21). S.
aureus and E. coli are well-studied mastitis pathogens in the con-
text of host–pathogen interaction and the elucidation of their
genes, along with host immune response genes, is launching new
studies in functional genomics (20). Understanding sequence data
and locating functional SNPs in both the host and pathogen is
expected to reveal relationships between immune function and
the relevant genes that have the potential to advance resistance to
specific pathogens.
Treatment of mastitis is given on the premise that treatment
costs will be outweighed by production gains resulting from
elimination of infection. Most farms have established mastitis
management programs and include strategies such as routine
whole herd antibiotic therapy, culling of chronically affected cows,
post milking teat disinfection, as well as ensuring routine mainte-
nance of milking machines (7, 14). Due to high treatment costs,
lost income due to discarded milk, public health, and animal wel-
fare concerns, it would be advantageous for dairy cattle to resist
or mount effective immune responses to clear the wide variety
of mastitis-causing pathogens. In the case of mastitis, the abil-
ity to control or tolerate the infection without actually clearing
the pathogen, a phenomena known as resilience or tolerance
(22), is not sufficient given that dairy products are consumed
by human beings and are expected to be free of all potentially
harmful pathogens. Antimicrobial treatment has the potential to
increase the risk of antibiotic resistant strains of bacteria emerging
in the environment (23), although it has been suggested that scien-
tific evidence does not support emerging resistance in pathogens
isolated from dairy cows (24). Nonetheless, other non-antibiotic
treatment strategies are clearly warranted. Additionally, decreas-
ing the incidence of mastitis would contribute to increased animal
welfare as severe signs are associated with pain and discomfort for
the cow (25).
Mastitis is a problem that plagues dairy cattle worldwide; how-
ever, this review will focus on the mastitis situation in the most
economically developed countries. We highlight the genetic reg-
ulation of the bovine immune system and its vital contributions
to disease resistance, in particular mastitis. Current genetic selec-
tion approaches used in the dairy industry to reduce the inci-
dence of disease are reviewed, including the HIR technology; the
Immunity+™ sire line, as well as genomics to improve disease
resistance or immune response. While the complex interactions
of the host and pathogen are fully acknowledged, they are only
briefly discussed here.
GENETIC REGULATION OF THE IMMUNE SYSTEM
Robust, appropriate and timely host defense mechanisms are crit-
ical for prompt bacterial clearance and prevention of mastitis and
mammary epithelial damage (14). Bacteria have a large repertoire
of virulence factors that are produced at varying concentrations
depending on the stage of infection (26), and these virulence fac-
tors in part determine differences in the magnitude and duration
of host immune responses. Further, given the diversity of mastitis-
causing pathogens, it is essential for the host to have a broad range
of host-defense mechanisms as part of its immunological arsenal.
Both innate and adaptive host defenses are required to protect the
host from infection. Innate defenses against mastitis pathogens are
rapid and include neutrophil recruitment to the mammary gland
to facilitate bacterial clearance through phagocytosis, production
of reactive oxygen species, antibacterial peptides, such as lacto-
ferrin and β-lactoglobulin, and defensins, resulting in increases
in the somatic cell count (18, 27). Mammary epithelial cells are
known to play a role in early responses through the production of
cytokines like IL-8 and other factors with antimicrobial activities
(28, 29). If the bacteria survive these innate host defenses, adap-
tive immune responses mediated by T and B cells are required
to clear the infection (30). The ideal immune response being one
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that appropriately recognizes epitopes on the invading pathogen
to initiate swift and accurate clearance mechanisms while main-
taining minimal pathological consequences. In some situations,
such as experiments using in vitro or in vivo lipopolysaccaride
challenge to measure bovine inflammatory responses, particularly
IL-8, have noted that cows with lower IL-8 responses had quicker
recovery in terms of somatic cell counts and milk production
than those with high IL-8 production (31). This may relate to
a more moderate inflammatory response generated in these low
IL-8 responders. However, it is important to note that this does
not mean that cows classified as low responders for other immune
response mechanisms, particularly adaptive immune responses are
advantageous. In fact, dairy cows classified as high responders
(robust and balanced responses) for adaptive immune response
traits have been demonstrated to have reduced disease incidence
(32). The other thing worth noting in these experiments was
the observation that the differences between high and low IL-
8 responses seemed to be controlled by epigenetic effects (33).
Epigenetic influences on bovine type 1 (Interferon-γ) and type
2 (IL-4) cytokine production have also been reported in cows
classified as high or low responders based on their antibody and
cell-mediated immune responses (34). Researchers are only begin-
ning to dissect both the genetic and epigenetic mechanisms that
control immunity.
Initiation and regulation of adaptive immune responses are
critical to the resolution of infection. Cells of the innate immune
system recognize conserved pathogen associated molecular pat-
terns from the bacteria by binding pattern recognition receptors on
antigen-presenting cells (APC) such as macrophages and dendritic
cells (35). Such pattern recognition receptors include toll-like
receptors (TLR) that are located on cell and endosomal mem-
branes (27, 36). The association of a TLR with a pathogen asso-
ciated molecular pattern initiates a downstream signaling cascade
leading to the activation of transcription factors, such as NF-κβ,
which enter the nucleus, bind target promoters, and may induce
the production of cytokines and other endogenous mediators. The
10 mammalian TLRs are known to elicit unique responses through
intracellular signaling pathways, which initiate inflammatory and
antimicrobial processes to eliminate the pathogen (36, 37). For
example, the recognition of lipopolysaccharide (LPS) from E. coli
by TLR4, facilitated by additional proteins including CD14, LPS
binding protein, and myeloid differentiation protein, is associated
with production of TNF-α, IL-1β, IL-6, and IL-8. The lipoteichoic
acid of Gram positive bacteria like S. aureus recognized by TLR2
is associated with only transient increases in TNF-α and IL-1β
as well as IgG2 (27). It is well recognized that E. coli induces
a stronger increase in the pro-inflammatory cytokines TNF-α
and IL-1β compared to S. aureus (12, 27, 38), contributing to
the severe clinical signs typically associated with E. coli mastitis
as compared to S. aureus where the majority of cases go unno-
ticed. This draws attention to the fact that although the innate
immune responses provide a first line of defense against invad-
ing microbial pathogens, including those that cause mastitis, and
contours ensuing adaptive immune responses; innate responses
have the potential to generate harmful pathology by driving inap-
propriate or soaring inflammatory cascades (31). These need to
be carefully considered and closely monitored when considering
immunological interventions.
The major histocompatability complex (MHC) plays an essen-
tial role in the induction and regulation of immune responses (39).
The bovine MHC, bovine lymphocyte antigen (BoLA), has been
associated with resistance or susceptibility to mastitis (40–43),
somatic cell count (42, 44, 45), and immune response (40, 41, 46).
Genetic variation, such as single nucleotide polymorphisms (SNP)
in other candidate genes associated with resistance or suscepti-
bility to mastitis have been identified, including TLR4 (47, 48),
TLR2, and caspase-recruitment domain 15 (49); IL-10 (50), osteo-
pontin (51), IL-8 and its receptor CXCR1 (52–54), CCL2 and its
receptor (55), as well as a variety of other genes (56). Other mole-
cules important in host defense against mastitis-causing pathogens
such as β-defensins have been identified and their complex genetic
regulation is beginning to be understood (57). The feasibility of
breeding for resistance based on one SNP or a combination of SNP
depends on the degree of variation each SNP explains in resistance
to mastitis. Since mastitis is a complex genetic trait a combination
of many genes will ultimately be responsible for resistance to mas-
titis; however, certain major genes may contribute more benefit
than others and it is important that these genes be elucidated.
Recent studies are beginning to uncover information about
the epigenetic influences on bovine immune response genes (58).
Some studies are now indicating that epigenetic changes are
involved in the regulation of type I and II immune responses of
mammals (59, 60), including cytokine profiles of dairy cows dur-
ing the peripartum period when the risk of mastitis is the greatest
(34). Epigenetic modifications have also been demonstrated to
play a role in bovine innate immune responses to LPS stimulation
(33, 61). Further, microRNA have been found to be differen-
tially expressed upon challenge with mastitis-causing pathogens,
suggesting a role for microRNA in regulating host responses to
mastitis (62, 63). Indeed, many studies have demonstrated the
bovine immune response to be under genetic and epigenetic con-
trol, and making use of this information in breeding strategies is
anticipated to help improve udder health.
The important question is how to use this information regard-
ing genetic associations with mastitis and the immune system
to actually improve disease resistance. This is not necessarily a
straight forward question given the plethora of genes, including
their additive, dominant, epistatic, and epigenetic interactions. It
is sometimes possible to make genetic gains in livestock health to a
particular disease by selecting for or against a specific gene. Some
examples of this include selection against Mareks Disease of poul-
try based on MHC haplotypes (64), bovine dermatopholosis using
information on BoLA (65), brachyspina in cattle (66) among oth-
ers (67). It is generally straightforward to make genetic gains for
diseases caused by single recessive disorders, whereas information
on single genes or clusters of genes may be less informative when
trying to enhance resistance to complex traits, such as mastitis
resistance, which is caused by a diverse set of pathogens controlled
by a large variety of genes and gene interactions (68).
It is also worth noting that the immune system, which is the
body’s main host defense system, is regulated by thousands of
genes (69). This points to the critical importance and complex
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nature of disease resistance as an overall fitness trait (70, 71). In
fact, recent information from a human systems biology data base
on immunity known as the immunogenetic-related information
source – IRIS provides evidence for 1,535 immune response genes
as of April 20131. This list of genes was curated by IRIS with
the following strict definition of a bona fide immune response
gene, “a complete gene that produces a functional transcript and
demonstrates at least one of the following defense characteristics:
(i) known or putative function in innate or adaptive immunity,
(ii) participates in the development or maturation of immune
system components, (iii) induced by immunomodulators, (iv)
encodes a protein expressed primarily in immune tissues, (v) par-
ticipates in an immune pathway that results in the expression of
defense molecules, (vi) produces a protein that interacts directly
with pathogens or their products”2. When a broader definition
of immune response genes are given that seeks to retrieve all
genes that have some immune system or related functions, such
as that provided by the Immunology Database and Analysis Portal
(ImmPort), the list of genes is in the range of 60003. Although
these databases are based on human genes the newest version
of the innate immunity database, InnateDB, does incorporate a
list of bovine genes, including pathway and molecular interac-
tions4. As pointed out by Karin Breuer and colleagues, as the
experimental data from cattle research validates genetic interac-
tions and immunological pathways this will allow for a deepened
understanding of important bovine diseases, such as mastitis and
tuberculosis (69). At the moment, these immunological databases
rely largely on orthological-based approach to predict pathways.
As of September 2012, the InnateDB contained more than 70,000
bovine interactions based on orthology and pathway analysis could
assign to more than 7000 bovine genes (69). However, since the
bovine immune system does contain some unique genetic features,
such as a novel bovine type 1 interferon family known as IFNX,
it will not always suffice to rely on orthogues from other species.
Nonetheless, it is interesting to speculate about similar genetic
pathways. For example, work in human beings has shown that fol-
lowing exposure to bacterial endotoxin a set of 3,714 unique genes
were differentially expressed. These changes in genes of interest
were confirmed in follow-up microarray experiments (72). Sim-
ilar transcriptional changes might be predicted in cattle exposed
to endotoxin from E. coli following intramammary exposure (73),
as the complex plethora of genes involved in response to mastitis,
such as that caused by E. coli is well known (74–76). The goal of
this type of systems biology research is to provide a portrait of
the entire “interactome between the innate and adaptive immune
system, as well as its interconnection with other body systems in
the hopes to enhance disease prevention and treatment strategies.
GENETIC SELECTION FOR DISEASE RESISTANCE
Current genetic selection approaches to improve mastitis resis-
tance include both direct and indirect methods. With the exception
of Nordic countries that have been selecting for disease resistance
1http://www.innatedb.com/curatedGenes
2http://www.innatedb.com/redirect.do?go=resourcesGeneLists
3http://www.immport.org
4http://www.innatedb.com
for over 35 years (77), most countries breed for mastitis resis-
tance indirectly through SCC (78). More recently, France (79) and
Canada (80) have launched routine national genetic and genomic
evaluations for clinical mastitis. Problems associated with breed-
ing directly for mastitis resistance include low heritability, the need
for accurate health recording, and perhaps most importantly, the
potential to skew the immune system causing individuals to be
susceptible to other harmful pathogens. This skewing is thought
to occur since antibody and cell-mediated immune responses are
independent or slightly negatively correlated traits (81–84). This
means that improvement for one of these traits does not translate
into improvement of the other adaptive immune response trait.
This concept will be discussed in more detail.
The heritability of mastitis resistance is low, with estimates
ranging from about 0.02–0.10 (85, 86). SCS is genetically cor-
related (0.7) with mastitis and has a higher heritability of about
0.17, which is why it is used as an alternative trait to breed for
resistance to mastitis (87–89). Divergent selection experiments
based on SCS in sheep and cattle have been performed with the
goal of creating lines of animals with an ability to resist intra-
mammary infection (90, 91). Although these studies have shown
a decrease in mastitis in the low SCS line, caution must be used
in this approach to improve udder health. SCS tends to monitor
subclinical cases (92) and although decreasing bulk tank counts
has been associated with a decline in subclinical mastitis; clin-
ical mastitis continues to be a problem (93). Further, since the
cells that constitute the SCS are cells of the immune system, too
low a SCS has been associated with an increased risk of clinical
mastitis (94). In Canada, the approach will be to equally weight
clinical mastitis and SCS in the LPI starting in August 2014. Other
immune response traits known to associate with resistance to
various diseases, including mastitis, may be added subsequently,
although sires with improved immune responses are already avail-
able through the Canadian breeding company, the Semex Alliance
since December 2012 (32).
In order to select directly for mastitis resistance,accurate disease
records are essential. Many countries record disease on a volun-
tary basis, as is the current situation in the United States (86,
95) and Canada (85, 96). The use of voluntary producer records
has brought into question the reliability of the estimates for dis-
ease resistance. By applying minimum lactation incidence rates to
producer-recorded data to include only herds with regular record-
ing, it has been found that although the heritability of disease
resistance tends to be low (0.01–0.20) significant genetic variation
exists to select for disease resistance (85, 95–97). Some research
has demonstrated the use of genomics to improve the reliability
of genetic estimates for disease resistance traits (86).
Selection against clinical mastitis has the potential to leave cattle
susceptible to infection with other mastitis pathogens, since bacte-
ria require unique immune responses for host protection (2), and
mastitis pathogens have been demonstrated to change over time
and geographically (7). Further, mastitis-causing pathogens tend
to be extracellular in nature, requiring robust antibody responses
(98). Since antibody- and cell-mediated immune responses tend to
be negatively genetically correlated (83, 84) selection for mastitis
resistance may potentially leave individuals with diminished capa-
bility to respond to intracellular pathogens generally controlled
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by the cell-mediated immune response. Cell-mediated responses
have been demonstrated to be critical in controlling Mycobac-
terium avium spp tuberculosis, the causative pathogen associated
with Johne’s disease in cattle (99). Maintaining balanced immune
responsiveness is an essential consideration in any breeding pro-
gram to improve animal health. The other contributing factor
is that different BoLA alleles have been shown to associate with
antibody versus cell-mediated immune responses, as well as mas-
titis resistance (41). However, these are not the same alleles that
associate with resistance to other viral or parasitic pathogens (100,
101). Therefore, caution must be exercised when selecting for resis-
tance to one specific disease, particularly when it can be caused
by multiple pathogens, as is the case with mastitis. Nonetheless,
mastitis is such a costly disease that it is likely to be included in
selection indices in conjunction with other health traits, such as
SCS, until alternative approaches based on optimizing host defense
mechanisms are more widely available. For example, in Canada
an index for mastitis resistance was developed that includes both
clinical mastitis and SCS traits and will be added to the Lifetime
Profitability Index (LPI) in August 2014 (102, 103).
A combination of approaches is likely necessary to decrease
mastitis occurrence, such as breeding for broad-based disease resis-
tance based on immune response traits. Breeding for enhanced
immune responsiveness is a solution to provide cows with an
overall superior ability to respond to a variety of pathogen types
requiring unique responses to provide broad-based disease resis-
tance. Individuals with greater and optimally balanced antibody
and cell-mediated immune responses breeding values are referred
to as high immune responders (HIR) (Figure 1) and the method
for identifying such individuals is referred to as the HIR technology
(32, 104).
The HIR technology has been used to identify the ability of
cows, calves, and bulls to mount antibody and cell-mediated
adaptive immune responses (106, 107). These adaptive immune
response traits are heritable, on average 0.25–0.35 (83, 84), con-
siderably higher than estimates for specific clinical or subclinical
disease resistance (Table 1). The heritability of immune response
is similar to what has been found for milk production traits,
indicating it would be possible to make significant genetic gain
depending on how heavily health is weighted within the selec-
tion index. Cows with superior adaptive immune responses have
been demonstrated to have substantially lower occurrence of dis-
eases, including mastitis, metritis, displaced abomasums, retained
fetal membranes (108) and are less likely to be seropositive for
Mycobacterium avium spp paratuberculosis (109). It would, there-
fore, be feasible and desirable to breed dairy cows for enhanced
immune responses to decrease the occurrence of diseases like mas-
titis (100, 110). Previously, this approach was shown to improve
disease resistance of pigs (105). It should also be noted that pro-
ducing robust adaptive immune responses requires appropriate
priming via particular innate host defense pathways, such as TLR
signaling (37). Priming the immune system with LPS in the udder
has been shown to reduce bacterial load in experimentally induced
mastitis via the TLR signaling (111, 112).
High immune responding cows have also been found to have
an increased response to commercial E. coli J5 mastitis vaccina-
tion (117), as well as improved colostrum quality as measured by
FIGURE 1 | Overview of immune response adapted from Ref. (105). The
host immune response phenotype is ultimately determined by the
interaction of the immune response genotype with the environment. The
expression of the immune response genotype is also regulated by
epigenetic effects. The innate immune response is relatively fast acting and
non-specific, but is critical to signal appropriate adaptive cell-mediated and
antibody-mediated immune responses. Dairy cattle with enhanced and
balanced cell and antibody-mediated immune responses are known as high
immune responders.
Table 1 | Heritability estimates of immune response, mastitis
resistance, and milk production and in Holstein dairy cattle.
Trait Heritability Reference
Antibody-mediated
immune response
0.16–0.42 Heriazon et al. (84),
Thompson-Crispi et al. (83)
Cell-mediated
immune response
0.19–0.43 Heriazon et al. (84),
Thompson-Crispi et al. (83)
Generalized immunity 0.21 Abdel-Azim et al. (113)
Mastitis 0.02–0.10 Bloemhof et al. (87), Koeck et al.
(85, 114), Parker Gaddis et al.
(86), Pritchard et al. (115)
Somatic cell score 0.11–0.17 Bloemhof et al. (87), Jamrozik
and Schaeffer (88), Koeck et al.
(85, 114), Pritchard et al. (115)
Milk yield (305 days) 0.14–0.30 McCarthy and Veerkamp (116),
Pritchard et al. (115)
specific antibody (117), total immunoglobulin, lactoferrin, and β-
lactoglobulin (118). Differences in leukocyte populations between
high and low immune responders have also been described, such
that cows with superior antibody responses have a higher propor-
tion of B cells in peripheral blood in response to immunization,
whereas cows with high cell-mediated responses have a higher
baseline proportion of gamma delta (γδ) T cells (119). These dif-
ferences in the diverse phenotypes identified using the HIR tech-
nology suggest potential mechanisms that contribute to decreased
disease occurrence among high immune responding individuals.
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Multiple studies over many years have found beneficial asso-
ciations between antibody responses and a lower occurrence
of mastitis. A study that evaluated antibody-mediated immune
responses to a specified test antigen found cows with superior
antibody responses had lower occurrence of mastitis in two out
of three herds tested (117). Subsequently, cows with greater anti-
body responses in a commercial herd in Florida were found to be
1.6–2.5 times less likely to get clinical mastitis compared to other
cows in the herd (108, 120). Most recently, a nation-wide study
in Canada evaluating the incidence rate of clinical mastitis over a
2-year study period found cows with superior antibody responses
to have an incidence rate of 17.1 cases of clinical mastitis/100 cow
years compared to average and low responding cows with 27.9
and 30.7 cases, respectively. The low responding cows were also
found to have more severe mastitis compared to cows with better
immune responses (98). Antibody-mediated immune responses
have also been beneficially genetically correlated with some repro-
ductive traits as well as longevity, suggesting that cows with better
immune responsiveness and therefore, less disease remain in the
herd longer (83).
Conversely, cows with greater cell-mediated immune responses
have been found to be less likely to be seropositive for Mycobacteria
avium paratuberculosis (109). Cell-mediated immune responses
are also critical to provide protection against S. aureus small colony
variants that can cause mastitis and have the ability to survive
within host cells (6, 21). Antibody and cell-mediated immune
responses have been found to be negatively genetically correlated
(83, 84). Consequently, in order to ensure protection to a broad
range of pathogens it is essential to identify and select individ-
uals with the capacity to generate both effective antibody and
cell-mediated immune responses (32).
The Semex Alliance utilizes the HIR Technology to identify
dairy sires with superior immune responsiveness, termed Immu-
nity+™. Daughters of Immunity+™ sires have been found to have
lower disease occurrence and higher profitability compared to
daughters of sires with either an unknown or an average or low
immune response type. Specifically, daughters of Immunity+™
sires in a large herd in the US had a 44% reduction in mastitis,
25% less calf pneumonia, and an 8.5% reduction in all diseases
in first lactation heifers (32). These results highlight the benefit
and potential to improve disease resistance, in particular mastitis
resistance, by improving overall immune responsiveness.
Genomic selection has allowed for the opportunity to include
new phenotypes in breeding objectives, particularly those that
may be relatively expensive to measure (121). Genomic selection
refers to breeding decisions based on genomic estimated breed-
ing values (GEBV), which are calculated using the joint effects
of SNP markers across the entire genome (122–124). Using a
large reference population with accurate phenotype information,
the SNP or haplotype effects for a given trait are estimated. In
subsequent generations, only information on the SNP or haplo-
types are required to calculate the GEBV (123). Genomic selec-
tion has provided many substantial benefits to the dairy indus-
try. Perhaps the most highlighted benefit is in the significant
increase in the rate of genetic gain by decreasing generation
interval, increasing, and selection intensity the accuracy of esti-
mates (122).
The sequencing of the bovine genome and release of SNP arrays
used for genomic selection has led to increases in the genome-wide
association studies (GWAS). Many GWAS have been performed,
which has lead to the identification of quantitative trait loci or
SNP profiles associated with resistance or susceptibility to mas-
titis (125), or SCC as an indicator of mastitis (126–128). Using
the approach, many genes involved in immune response have
been found, including cytokines IL-4 and IL-13 as well as IL-
17 (129). Recently, a series of GWAS have been performed for
general immune responsiveness in dairy cattle and results have
been validated in dairy sires (46). Results of this work have identi-
fied many genes associated with immune responses including the
bovine MHC, the complement systems as well as cytokines includ-
ing IL-17 and TNF in the genetic regulation of bovine immune
system. Results of these GWAS on mastitis resistance and immune
response suggest that it is possible to calculate GEBV for mastitis
or immune response traits increasing the accuracy of estimates
for genetic selection. The next critical steps are to create large ref-
erence populations with genotypes and accurate phenotypes for
disease and immune response traits in order to improve dairy
cattle health.
CONCLUSION
The ideal solutions to improve resistance to mastitis are likely
to be those that focus on a large number of genes, by using
information from GWAS, or selection based on breeding values
of immune responses, which take into account complex genetic
interactions between the innate and adaptive host defense mecha-
nisms without the necessity of knowing all about each individual
gene. Using selection indices also offers the advantage of being
able to easily adjust the weights given to the various traits within
the index as the selection proceeds. These two approaches may
be best suited to help alleviate mastitis, at least until we gain more
knowledge about genetic and epigenetic regulation of host defense
mechanisms.
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